Story perspectives

PACT Biotech Accelerates Cell Therapy Innovations at UW

9/13/2025

29 3

Summary

Story summary

PACT, a biotech startup within a hospital, focuses on cell manipulation for treating diseases like cancer and autoimmune disorders.
The University of Washington has been a leader in cell therapy since 1968, beginning with successful bone marrow transplants.
Unlike bone marrow transplants, lab-manipulated cells require FDA approval, which PACT accelerates through UW's resources.
PACT's strengths include a robust research program, experienced clinical trial teams, on-site manufacturing, and regulatory knowledge.
Founded in 2016, PACT obtained its first FDA Investigational New Drug authorization in 2020, securing eight licenses for innovative research.

1 of 1

Story summary

PACT, a biotech startup within a hospital, focuses on cell manipulation for treating diseases like cancer and autoimmune disorders.
The University of Washington has been a leader in cell therapy since 1968, beginning with successful bone marrow transplants.
Unlike bone marrow transplants, lab-manipulated cells require FDA approval, which PACT accelerates through UW's resources.
PACT's strengths include a robust research program, experienced clinical trial teams, on-site manufacturing, and regulatory knowledge.
Founded in 2016, PACT obtained its first FDA Investigational New Drug authorization in 2020, securing eight licenses for innovative research.